Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer

ErbB2 is an important member of the ErbB family, which activates growth and proliferation signaling pathways. ErbB2 is often overexpressed in various malignancies, especially in breast cancer, and is a common target for anti-cancer drugs. Breast cancer is currently one of the leading mortality cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolfson, Eya, Goldenberg, Maria, Solomon, Shira, Frishberg, Amit, Pinkas-Kramarski, Ronit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323158/
https://www.ncbi.nlm.nih.gov/pubmed/27542246
http://dx.doi.org/10.18632/oncotarget.11323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323158/
https://www.ncbi.nlm.nih.gov/pubmed/27542246
http://dx.doi.org/10.18632/oncotarget.11323

Ejemplares similares